Article Text

Download PDFPDF

A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease
  1. J A van Noorda,
  2. Th A Bantjeb,
  3. M E Elandc,
  4. L Korduckid,
  5. P J G Cornelissen on behalf of the Dutch Tiotropium Study Groupd
  1. aDepartment of Respiratory Diseases, Atrium Medisch Centrum, Heerlen, The Netherlands, bDepartment of Respiratory Diseases, Ignatius and Baronie Hospitals, Breda, The Netherlands, cDepartment of Respiratory Diseases, Merwede Hospital, Dordrecht, The Netherlands, dBoehringer Ingelheim, Ridgefield, CT, USA and Alkmaar, The Netherlands
  1. Dr J A van Noord, Department of Respiratory Diseases, Atrium Medisch Centrum, Henri Dunantstraat 5, 6419 PC Heerlen, The Netherlands

Footnotes

  • The members of the Dutch Tiotropium Study Group include: Th A Bantje, Breda; J M M v d Bosch, Nieuwegein; M C M Bunnik, Boxmeer; M E Eland, Dordrecht; S J M Gans, Harderwijk; H Ch Gooszen, Eindhoven; J H L M van Kasteren, Geldrop; J A van Noord, Heerlen; G D Nossent, Groningen; A Peters, Blaricum; W R Pieters, Helmond; P E Postmus, Amsterdam; H E J Sinninghe Damsté, Almelo; A P Sips, Utrecht.

  • Funding: This study was supported by a grant from Boehringer Ingelheim BV, Alkmaar, The Netherlands.

View Full Text

Statistics from Altmetric.com

Footnotes

  • The members of the Dutch Tiotropium Study Group include: Th A Bantje, Breda; J M M v d Bosch, Nieuwegein; M C M Bunnik, Boxmeer; M E Eland, Dordrecht; S J M Gans, Harderwijk; H Ch Gooszen, Eindhoven; J H L M van Kasteren, Geldrop; J A van Noord, Heerlen; G D Nossent, Groningen; A Peters, Blaricum; W R Pieters, Helmond; P E Postmus, Amsterdam; H E J Sinninghe Damsté, Almelo; A P Sips, Utrecht.

  • Funding: This study was supported by a grant from Boehringer Ingelheim BV, Alkmaar, The Netherlands.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.